Overview
A medical necessity denial is a clinical denial where the payer determines a service was not reasonable and necessary for the diagnosis, treatment, or improvement of the patient's medical condition. "Medical necessity" is the core coverage standard for most healthcare services; Medicare defines it as services reasonable and necessary for diagnosis or treatment of illness or injury or to improve functioning of a malformed body member. Commercial payers use similar definitions, often refined by payer-specific clinical policies.
Medical necessity denials occur at both pre-service (prior authorization denied) and post-service (retrospective denial after claim submission) stages. Pre-service denials allow the clinical team to modify the care plan, provide additional documentation, or forgo the service. Post-service denials require appeal and may leave the provider uncompensated for services already delivered.
Payer criteria for medical necessity adjudication typically include InterQual (managed by Change Healthcare) and MCG (formerly Milliman Care Guidelines), which are proprietary clinical criteria covering admission status, level of care, length of stay, and specific procedures. Payers also publish their own clinical policies (CPs or medical policies) for specific services — e.g., criteria for coverage of surgical robots, advanced imaging, specialty pharmacy. Provider organizations often maintain InterQual/MCG licenses to align their own documentation with payer criteria.
Appeals for medical necessity denials require clinical documentation supporting the criteria: clinical history demonstrating the indication, physical examination findings, diagnostic results, therapeutic trials, and documentation of the clinical decision-making. Appeal letters reference the applicable criteria (InterQual, MCG, payer CP), cite clinical literature, and explain why the service was reasonable and necessary. Physician advisors typically author appeal letters; peer-to-peer discussions with payer medical directors may be requested.
Medicare appeal ladder for medical necessity denials proceeds through Redetermination (Level 1, by MAC), Reconsideration (Level 2, by QIC), ALJ hearing (Level 3), Medicare Appeals Council (Level 4), and Federal District Court (Level 5). Each level has specific timelines (Redetermination: 60 days to request, 60 days for MAC decision) and evidentiary rules. Commercial payers generally offer internal appeal levels followed by external review through independent review organizations (IROs) under state or federal law.
For RCM operations, medical necessity denial management requires specialized expertise: physician advisors with clinical credentials, InterQual/MCG licensure and training, appeals writing skills, and payer relationship understanding. Service lines with high medical necessity denial exposure include cardiology (stress tests, cardiac imaging), orthopedics (joint replacement indications), oncology (chemotherapy protocols), bariatric surgery (BMI and comorbidity criteria), and behavioral health (length-of-stay appropriateness).
Root cause analysis of medical necessity denials typically points to documentation quality gaps (insufficient clinical documentation to support the service), payer-specific criteria variation (criteria the treating team was not aware of), and utilization management process gaps (concurrent review not engaged with payer during the admission). Effective medical necessity denial management combines robust CDI programs, concurrent utilization management, physician advisor engagement, and post-service appeal expertise.
Financial impact varies by service. High-dollar surgical and imaging denials may warrant aggressive multi-level appeal investment; lower-dollar E/M medical necessity denials may not justify the appeal cost. Organizations track appeal ROI (recovery per appeal dollar spent) to optimize denial management investment. Mature programs selectively pursue denials where appeal probability and dollar amount justify effort, while writing off lower-value denials.
Industry benchmark
Medical necessity appeal success rates: 50–70% at first level when well-documented. InterQual/MCG: dominant payer criteria sets. Medicare appeal ladder: 5 levels.
Worked example
A Medicare patient undergoes elective cardiac stress test. The MAC retrospectively denies as not medically necessary because documentation does not clearly establish pre-test probability of coronary disease. The physician advisor reviews the chart, identifies documented chest pain, age, and risk factors meeting CMS coverage criteria, and writes a Redetermination appeal citing the applicable Local Coverage Determination (LCD). The MAC overturns the denial based on the appeal documentation.
Frequently asked questions — Medical Necessity Denial
What criteria do payers use for medical necessity?
InterQual (Change Healthcare) and MCG (formerly Milliman) are dominant. Payers also publish proprietary clinical policies. Medicare uses LCDs and NCDs. Appeal documentation should reference the applicable criteria set.
What is the typical appeal success rate?
50–70% at first level when well-documented. Success rates decline at subsequent appeal levels. Strong clinical documentation is the primary success driver.
Can pre-service denials be converted to post-service approvals?
Not automatically. Pre-service denials typically require the clinical team to modify the plan or accept non-coverage. Post-service appeal of a pre-service denial has limited success unless new clinical information emerges.
Disclaimer
This glossary entry is operational reference for revenue-cycle and medical-billing professionals. It is not legal, clinical, or contractual advice. Industry benchmarks cite named public sources where available; always verify against the current guidance from the authority body before relying on a number in a contract, policy, or compliance filing.